849217-68-1Cabozantinib (XL184, BMS-907351)

0.00 0.00

商品编号:

库存现货:

顾客评分:
(已有0人评价)
购买数量:
+ -
  • 商品名称:849217-68-1Cabozantinib (XL184, BMS-907351)
  • 商品毛重:
  • 单位:件
  • 上架时间:2017-11-01 18:29:55

名称: Cabozantinib (XL184, BMS-907351)英文名称: Cabozantinib (XL184, BMS-907351)≥98%产品编号 C126195
CAS号: 849217-68-1分子式 C28H24FN3O5分子量501.52

属性

溶解性 Soluble in DMSO (100 mg/ml at 25 °C), water (
存贮条件 储存温度-20°C

描述

产品介绍 Cabozantinib (XL184, BMS-907351)是一种有效的VEGFR2抑制剂,靶向作用于VEGFR2和c-Met时,IC50为0.035 nM ,也有效抑制c-Met、 Ret、 Kit、Flt-1/3/4、Tie2和AXL,IC50分别为1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM。
别名 BMS-907351;博卡替尼;卡博替尼;卡赞替尼;N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺;XL184; BMS-907351; XL-184; XL184;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
生化机理 XL184 (Cabozantinib) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM. XL-184 also displays potent activity against Met, Ret, Kit, FLT1, FLT3, FLT4, Tie2, and AXL. XL184 at low concentration (0.1-0.5 μM) is sufficient to induce marked inhibition of constitutive and inducible Met phosphorylation and its resultant downstream signaling in MPNST cells, and inhibit HGF-induced MPNST cell migration and invasion.
备注 Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively.Phas
应用 A potent VEGFR2 and Met inhibitor

购买人 出价 数量 购买时间 状态
我要咨询 购买前咨询(共0记录)
我要提讨论
  • 讨论内容

  • 验证码

  •  
返回顶部